You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Pediatric

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MRD Detection by NGS in Pediatric B-ALL

Completed
  • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
  • MRD
  • Hangzhou, Zhejiang, China
    The Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023

Next-generation Sequencing in Pediatric B-ALL Children Patients

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • (no location specified)
Apr 19, 2023

Acute Lymphoblastic Leukemia, Pediatric Trial (CareMeds Intervention, Usual Care Group)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • CareMeds Intervention
  • Usual Care Group
  • (no location specified)
Oct 12, 2023

Acute Lymphoblastic Leukemia, Pediatric Trial in Bratislava (Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518, Physical

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518
  • Physical exercise
  • Bratislava, Slovakia
    Department of Pediatric Hematology National Institute of Childre
Jul 12, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Vaccine Immune Recovery After Leukemia

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia, Pediatric
    • Observational only
    • Chicago, Illinois
    • +2 more
    Nov 9, 2022

    Pediatric Acute Lymphoblastic Leukemia

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia, Pediatric
    • Adverse Drug Event
      • Stanford, California
        Stanford University
      Mar 7, 2022

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

      Recruiting
      • Acute Lymphoid Leukemia
      • +3 more
      • São Paulo, SP, Brazil
        Instituto do Cancer do Estado de Sao Paulo
      Jul 24, 2023

      Parental Perception of Their Child's Emotional Quality of Life

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • Self-report questionnaires (only for parents)
      • +2 more
      • (no location specified)
      Oct 24, 2023

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia, Refractory Trial in Philadelphia

      Recruiting
      • Acute Myeloid Leukemia, in Relapse
      • +2 more
      • CART123 cells; cyclophosphamide; fludarabine
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Feb 28, 2022

      B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

      Not yet recruiting
      • B Precursor Acute Lymphoblastic Leukemia
      • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
      • (no location specified)
      Sep 25, 2023

      Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jul 21, 2023

      B Cell Lymphoma, Acute Lymphoblastic Leukemia, Pediatric, Lymphoma Trial in Stanford (Fludarabine, Cyclophosphamide, Autologous

      Suspended
      • B Cell Lymphoma
      • +2 more
      • Stanford, California
        Stanford Medical Center
      Sep 8, 2022

      CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

      Not yet recruiting
      • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
      • +3 more
      • (no location specified)
      Nov 14, 2022

      B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 10, 2023

      Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

      Recruiting
      • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 13, 2022

      B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • single dose of CNCT19
      • (no location specified)
      Dec 19, 2022

      Healthy Bones, Healthy Life

      Recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • +12 more
        • Omaha, Nebraska
          University of Nebraska Medical Center
        Dec 10, 2021

        ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

        Not yet recruiting
        • ALL, Childhood B-Cell
        • +2 more
        • Tafasitamab
        • (no location specified)
        Nov 25, 2022

        Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

        Recruiting
        • Acute Lymphoblastic Leukemia, in Relapse
        • +5 more
        • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
        • +4 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin
        Sep 22, 2022

        Acute Lymphoblastic Leukemia, Adult Trial in Caba (Evaluation of survival and toxicities in AYA Ph-negative ALL patients

        Recruiting
        • Acute Lymphoblastic Leukemia, Adult
        • Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.
        • Paraná, Entre Ríos, Argentina
        • +1 more
        Dec 29, 2022

        Pediatric and Young Adult B-Cell Malignancies After Commercially

        Not yet recruiting
        • Lymphoid Leukemia
        • Questionnaire for patients receiving therapy
        • Palo Alto, California
          Stanford University
        May 9, 2023

        According to Molecular Identification at Diagnosis

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Next Generation Sequencing (DNA and RNA)
        • (no location specified)
        Oct 28, 2022

        Lymphoblastic Leukemia, Acute, Childhood Trial in Jakarta Pusat (N-Acetylcysteine, Placebo)

        Terminated
        • Lymphoblastic Leukemia, Acute, Childhood
        • Jakarta Pusat, DKI Jakarta, Indonesia
          Dr Cipto Mangunkusumo National Hospital
        Nov 7, 2022